Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • ZPay To Be Launched On June 7th With Crypto Rewarding Solutions For Fearless Crypto Experience Business
  • BuySM.com – An Affordable & Cold Storage Super Speciality Medicine Business
  • Muscle Torque Launches a New Category of Cord Set in its Activewear Line Business
  • PAMS’ Growth+ program helps budding professionals to unlock their true potential Business
  • Prabhakar Baranwal: Nurturing Times Applaud Inspiring Leadership Excellence through REAL Approach Lifestyle
  • Deepika Padukone is the first Indian to be signed as a House Ambassador by Louis Vuitton Lifestyle
  • Toprankers Grand Learning Festival – Celebrating the Learning with Students   Business
  • A Heartwarming Mother’s Day Celebration at IDT Business

Optimus Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets

Posted on October 9, 2021 By dsprime 127 Comments on Optimus Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets

Hyderabad (Telangana) [India], October 09: Optimus Pharma Private Limited today announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for the generic equivalent of Rexulti® Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, of Otsuka Pharmaceutical Co., Ltd. Optimus Pharma’s approval for its Abbreviated New Drug Application (ANDA) BREXPIPRAZOLE Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, was received on October 8th, 2021. BREXPIPRAZOLE will be manufactured at Optimus Pharma’s Pashmylaram USFDA accredited facility in India.

BREXPIPRAZOLE Tablets (RLD: Rexulti® Tablets) had estimated annual sales of USD 1258 million in the U.S. (IQVIA MAT July 2021).

BREXPIPRAZOLE has a favourable antipsychotic profile in terms of improvement of cognitive performance and sleep patterns, as well as effects on affective states and potential to treat core symptoms in schizophrenia and major depressive disorder, including cognitive deficits with a low risk of adverse effects (extrapyramidal symptoms, metabolic complications, weight gain, akathisia potential) that are commonly encountered with other typical and second-generation antipsychotic drugs. From the studies done so far, it can be concluded that BREXPIPRAZOLE can be effective monotherapy for schizophrenia and as an adjunct to other antidepressant medications in major depressive disorder.

About Optimus Pharma

Optimus was established in the year 2004 as a custom synthesis laboratory by a team of techno-commercial experts. It is one of the fastest-growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages. Over the last decade, we have been certified and audited by reputed Global Regulatory Agencies like USFDA, WHO, COFEPRIS, EMA, KFDA and AFM from PMDA Japan. Optimus Pharma is a vertically integrated pharmaceutical company engaged in the manufacturing of Solid Oral and semisolid formulations. We have successfully integrated our API and Formulation R&D teams, with the IP and Regulatory Affairs team in order to ensure a dynamic product portfolio. We help our customers serve global markets with technology based, innovative, cost effective & consumer friendly products of the highest quality.

Business Tags:Business

Post navigation

Previous Post: Abhijeet Anand Awarded 2021 International Young Professional Service Award By SPE During Annual Technical Conference And Exhibition In Dubai
Next Post: Outsmart Your Competitors and Opt for Online Dominance with World’s Best SEO Services – ThatWare

Related Posts

  • Dinesh Kumar, Vice President of Jharkhand Archery Association, Empowering Sports in the State Business
  • TravelKaroo’s Franchise brings new opportunities for Unemployed Indians in tourism industry Business
  • Sunil Grover Recreates Shahrukh’s Chak De India Scene with a Delivery Twist for Dunzo Business
  • How BBNC.IN Has Become One Stop Solution for Business Owners Business
  • Catalyzing Economic Growth through Entrepreneurship and Innovation Business
  • HinDomain Announces Decentralized Domain Naming Service for India Business

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Rigi Launches GapUp: A Curated Discovery Platform Empowering Online Creators and Users
  • Ankit Shah listed amongst the “Most Admired Global Indians” by Passion Vista 
  • Hyderabad Astrologer Haritha Gogineni Honored as “Most Trusted Astrologer” at Times Business Awards 2023
  • BNI Prometheus welcomes new leadership team
  • Lifespan Hospitals, Nigeria collaborate to transform healthcare

Recent Comments

    • Rajnish Wellness Limited Receives an In-principle Approval from Eastern Railway for setting up of Business Centres at 500 plus railway stations Business
    • CityGlide builds a robust employee transport system in India English
    • Union Minister Smriti Irani Inaugurates the “Orphan Research and Development Academy Center” by Tarpan Foundation National
    • Influencerquipo Presents Emerging Beauty Content Creator of the Year – Shilpi Banda sets the way to Instagram Influencer! Lifestyle
    • Extending a Supporting arm for Business & Startups Business
    • CBTF Speed News associates with Iconic Gold Awards as presenting partner Entertainment
    • Necessary Measures for India’s Economic Competition with China Business
    • NAFED and Wendor Unite to Promote Millet-Based Products Across India: One Vending Machine at a Time National

    Copyright © 2023 Daily News India.

    Powered by PressBook News WordPress theme